All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Introducing

Now you can personalise
your Lymphoma Hub experience!

Bookmark content to read later

Select your specific areas of interest

View content recommended for you

Find out more
  TRANSLATE

The Lymphoma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Lymphoma Hub cannot guarantee the accuracy of translated content. The Lymphoma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
Visit:
ALL Hub

ALL Hub

AML Hub

AML Hub

GvHD Hub

GvHD Hub

Lupus Hub

Lupus Hub

MPN Hub

MPN Hub

Multiple Myeloma

Multiple Myeloma Hub

PsOPsA Hub

PsOPsA Hub

LOADING
You're logged in! Click here any time to manage your account or log out.
LOADING
You're logged in! Click here any time to manage your account or log out.
Steering CommitteeAbout UsNewsletterContact
SubtypesTherapeuticsCongressesTrialsExpert OpinionsDRUG UPDATES
2020-09-08T10:40:01.000Z

Update in HL from EHA 2020

By Claire Baker
Featured
Astrid Pavlovsky
Sep 8, 2020
Share:

Bookmark this article

During the 25th European Hematology Association (EHA) Annual Congress, the Lymphoma Hub was pleased to speak to Steering Committee Member Astrid Pavlovsky, Fundaleu CHP, Buenos Aires, AR. This interview outlines updates in Hodgkin lymphoma from EHA 2020.

Update in HL from EHA 2020

Here, Astrid Pavlovsky discusses two major topics when considering the treatment of Hodgkin lymphoma. Firstly, she outlines the latest on PET/CT-adapted treatments in the frontline setting, and secondly, she discusses the refinement and consolidation of combination regimens for the treatment of Hodgkin lymphoma.

More about...
EHA 2020Hodgkin lymphoma

Understanding your specialty helps us to deliver the most relevant and engaging content.

Please spare a moment to share yours.

Please select or type your specialty

  Thank you

Related articles

Add bookmark

Treating classical Hodgkin lymphoma that is refractory to salvage chemotherapy

As part of our biannual steering committee meeting, Astrid Pavlovsky, Fundaleu, Beunos Aires, AR, chaired a case study discussion session on treating a patient with...

Jul 27, 2022
Add bookmark

Treating classical Hodgkin lymphoma that is refractory to salvage chemotherapy

As part of our biannual steering committee meeting, Astrid Pavlovsky, Fundaleu, Beunos Aires, AR, chaired a case study...

Jul 27, 2022
Add bookmark

Dr. Astrid Pavlovsky | ASH 2017 | Brentuximab vedotin in cHL patients in Argentina

59th ASH Annual Meeting and Exposition, 9 - 12 Dec 2017, Atlanta, GA Dr Astrid Pavlovsky FUNDALEU, Buenos Aires, AR Therapy with brentuximab vedotin in cHL...

Dec 12, 2017
Add bookmark

Dr. Astrid Pavlovsky | ASH 2017 | Brentuximab vedotin in cHL patients in Argentina

59th ASH Annual Meeting and Exposition, 9 - 12 Dec 2017, Atlanta, GA Dr Astrid Pavlovsky FUNDALEU, Buenos Aires,...

Dec 12, 2017

Newsletter

Subscribe to get the best content related to lymphoma & CLL delivered to your inbox